Discovery of a potent M antagonist with improved clearance profile. Part 1: Piperidine amide-based antagonists
Authors
Capstick
RA
Rory A
,
Whomble
D
David
,
Orsi
DL
Douglas L
,
Felts
AS
Andrew S
,
Rodriguez
AL
Alice L
,
Vinson
PN
Paige N
,
Chang
S
Sichen
,
Blobaum
AL
Anna L
,
Niswender
CM
Colleen M
,
Conn
PJ
P Jeffrey
,
Jones
CK
Carrie K
,
Lindsley
CW
Craig W
,
Han
C
Changho
.
Bioorganic & medicinal chemistry letters. 2022 09 14; 76().
128988
Bioorganic & medicinal chemistry letters. 2022 09 14; 76().
128988
Abstract
The lack of potent and selective tool compounds with pharmaceutically favorable properties limits the in vivo understanding of muscarinic acetylcholine receptor subtype 5 (M) biology. Previously, we presented a highly potent and selective M antagonist VU6019650 with a suboptimal clearance profile as our second-generation tool compound. Herein, we disclose our ongoing efforts to generate next-generation M antagonists with improved clearance profiles. A mix and match approach between VU6019650 (lead) and VU0500325 (HTS hit) generated a piperidine amide-based novel M antagonist series. Several analogs within this series, including 29f, provided good on-target potency with improved clearance profiles, though room for improvement remains.